Pharmafile Logo
Pharmafocus logo
Advanced Search
lilly_building_with_american_flag_web

Canada secures 26,000 doses of Lilly therapy to treat COVID-19 in $32.5m deal

November 25, 2020
Manufacturing and Production, Research and Development COVID-19, Canada

The Canadian Government has partnered up with Eli Lilly to secure 26,000 doses of the company’s monoclonal antibody therapy bamlanivimab …

News
flu_vaccination_grippe_5115654021_5

Largest clinical trial treating mild to moderate COVID-19 patients to take place in Africa

November 25, 2020
Research and Development

The world’s largest clinical trial investigating the treatment of patients with mild to moderate COVID-19 is set to begin in …

News
1200px-eurotunnel_11

ABPI warns that no-deal Brexit could disrupt medicines and vaccine delivery

November 25, 2020
Research and Development

The Association of the British Pharmaceutical Industry (ABPI) has warned that the supplies of crucial medicines and vaccines could be …

News
1200px-oxycontin_branded_oxycodone_10mg_oc_side

Purdue Pharma pleads guilty to its role in the opioid crisis

November 25, 2020
Research and Development

Purdue Pharma has pleaded guilty to criminal charges over its role in fueling the opioid crisis which was driven by …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 25, 2020
Research and Development

The coronavirus news this week sees more companies release their coronavirus vaccine results, with Pfizer and BioNTech backing up their …

News
pharmafocus_december_2020_cover

The December 2020 issue of Pharmafocus is available to read free online now!

November 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing

The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …

News
fdaoutsideweb

FDA expands approval of Genentech’s Xofluza for post-exposure prevention of influenza

November 24, 2020
Manufacturing and Production, Sales and Marketing FDA, Xofluza, influenza

Genentech has secured FDA approval for Xofluza (baloxavir marboxil) for the post-exposure prevention of influenza in patients at least 12 …

News
british_houses_of_parliament

UK deaths currently a fifth higher than normal levels

November 24, 2020
Manufacturing and Production

Deaths across the UK are a fifth higher than normal, according to new government data.  Numbers released from UK Government …

News
vaccination-1215279_960_720

Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show

November 24, 2020
Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …

News
fda_white_oak_building_web_0

FDA approves Oxlumo for treating primary hyperoxaluria type 1

November 24, 2020
Manufacturing and Production

The FDA has approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1).  This rare genetic condition …

News

Sanofi’s invasive meningococcal disease vaccine approved for EU use in four serotypes

November 23, 2020
Research and Development, Sales and Marketing

Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …

News
dado_ruvic-illustration-reuters

Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy

November 23, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …

News
1200px-vaccine_image_1_1

Americans could get coronavirus vaccine by December, according to leader of Operation Warp Speed

November 23, 2020
Sales and Marketing

Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser …

News
fda_21_4_1_0

FDA grants Emergency Use Authorization for Regeneron’s antibody treatment

November 23, 2020
Sales and Marketing

The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …

News
jnjioffice_1

Johnson & Johnson set to pay $120 million in New York baby powder case

November 23, 2020
Sales and Marketing

A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …

News
1200px-logo_of_the_world_health_organization

World Health Organization does not recommend using remdesivir to treat COVID-19

November 20, 2020
Medical Communications

The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how …

News

Eli Lilly and Ypsome partner to advance automated insulin delivery system

November 20, 2020
Medical Communications

Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …

News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020
Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

News
influenza

First recombinant influenza vaccine approved in the European Union

November 20, 2020
Medical Communications, Sales and Marketing Europe, influenza, pharma

The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …

News
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

November 20, 2020
Medical Communications

The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026